Top compounds associated with response to CH507-9B2.9


Feature Type Standardized
Nominal ANOVA
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.099 0.003
mRNA pac-1 CTRPv2 pan-cancer AAC 0.11 0.005
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.005
mRNA piperlongumine CTRPv2 pan-cancer AAC 0.095 0.006
mRNA SRT-1720 CTRPv2 pan-cancer AAC 0.11 0.006
mRNA Parthenolide CTRPv2 pan-cancer AAC 0.11 0.006
mRNA CR-1-31B CTRPv2 pan-cancer AAC 0.095 0.007
mRNA Bortezomib CTRPv2 pan-cancer AAC 0.1 0.007
mRNA CIL55A CTRPv2 pan-cancer AAC 0.14 0.009
mRNA Cerulenin CTRPv2 pan-cancer AAC 0.092 0.01
Download CSV